Literature DB >> 15277996

Neutrophil elastase and interleukin-8 as inflammatory mediators in mechanically ventilated children.

Bozena Polańska1, Danuta Sidor, Iwona Leszczyk-Kapusta, Maria Niemczuk, Wanda Paradowska-Jeszke, Krystyna Ciborska, Adam Jankowski.   

Abstract

BACKGROUND: Neutrophil elastase is a proteolytic enzyme which can have a destructive effect on respiratory tract structures. Interleukin-8 (IL-8), a proinflammatory cytokine, is an important chemoattractant for neutrophils. The aim of our study was to assess inflammatory states by determining elastase in complex with alpha1-proteinase inhibitor (E-alpha1PI) and IL-8 in children requiring mechanical ventilation. MATERIAL/
METHODS: Plasma and respiratory tract lavage fluid (RTLF) levels of E-a1PI and IL-8 were measured (ELISA) in 31 children with (group I) and 22 without (group II) respiratory tract infection. Plasma results were compared with a group of healthy controls. Results are given as medians and ranges. Additionally, the percentage content of neutrophils in RTLF was determined.
RESULTS: Significantly higher (p<0.00004) plasma levels of E-alpha1PI were found in group I than in group II. In group II, there were significantly higher (p<0.002) RTLF levels of E-alpha1PI and IL-8 than in group I. In both groups, the percentage content of neutrophils in RTLF exceeded 60%. A negative correlation was found between the plasma and RTLF levels of E-alpha1PI (r=-0.69; p<0.0004), between E-alpha1PI and percentage neutrophil content (r=-0.6; p<0.006), and between IL-8 and percentage neutrophil content (r=-0.5; p<0.04) in RTLF in group II.
CONCLUSIONS: The determination of E-alpha1PI and IL-8 may be useful in the assessment of the inflammatory state in children requiring mechanical ventilation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277996

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  1 in total

1.  Elastase, α1-proteinase inhibitor, and interleukin-8 in children and young adults with end-stage kidney disease undergoing continuous ambulatory peritoneal dialysis.

Authors:  Bożena Polańska; Daria Augustyniak; Irena Makulska; Maria Niemczuk; Adam Jankowski; Danuta Zwolińska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-11-29       Impact factor: 4.291

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.